These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 19273790

  • 21. Secondary elevated IOP and cataracts after high-dose intravitreal triamcinolone and photodynamic therapy to treat choroidal neovascularization.
    Ruiz-Moreno JM, Montero JA, Amat P, Lugo FL.
    J Glaucoma; 2009 Jan; 18(1):69-72. PubMed ID: 19142138
    [Abstract] [Full Text] [Related]

  • 22. [Efficacy of three intravitreal injections of bevacizumab in the treatment of exudative age-related macular degeneration].
    Bidot ML, Malvitte L, Bidot S, Bron A, Creuzot-Garcher C.
    J Fr Ophtalmol; 2011 Jun; 34(6):376-81. PubMed ID: 21550687
    [Abstract] [Full Text] [Related]

  • 23. [ITAP - 6-month results of a prospective, randomised phase 3 study for evaluation of the combination therapy of PDT and intravitreal triamcinolone in exudative AMD].
    Gamulescu MA, Schubert K, Thormann S, Attaran M, Dueck N, Wiechens B, Spital G, Stroux A, Wachtlin J.
    Klin Monbl Augenheilkd; 2009 Jan; 226(1):60-5. PubMed ID: 19173165
    [Abstract] [Full Text] [Related]

  • 24. Comparison of intravitreal triamcinolone acetonide with photodynamic therapy and intravitreal bevacizumab with photodynamic therapy for retinal angiomatous proliferation.
    Saito M, Shiragami C, Shiraga F, Kano M, Iida T.
    Am J Ophthalmol; 2010 Mar; 149(3):472-81.e1. PubMed ID: 20053392
    [Abstract] [Full Text] [Related]

  • 25. Combination therapy of PDT and triamcinolone in CNV associated with fundus flavimaculatus.
    Braun B, Schneider U, Hasler P, Prünte C.
    Klin Monbl Augenheilkd; 2007 Apr; 224(4):353-5. PubMed ID: 17458813
    [Abstract] [Full Text] [Related]

  • 26. Intravitreal bevacizumab combined with photodynamic therapy for the treatment of occult choroidal neovascularization associated with serous pigment epithelium detachment in age-related macular degeneration.
    Ladas ID, Kotsolis AI, Papakostas TD, Rouvas AA, Karagiannis DA, Vergados I.
    Retina; 2007 Sep; 27(7):891-6. PubMed ID: 17891013
    [Abstract] [Full Text] [Related]

  • 27. Expression of endostatin in human choroidal neovascular membranes secondary to age-related macular degeneration.
    Tatar O, Shinoda K, Adam A, Rohrbach JM, Lucke K, Henke-Fahle S, Bartz-Schmidt KU, Grisanti S.
    Exp Eye Res; 2006 Aug; 83(2):329-38. PubMed ID: 16584730
    [Abstract] [Full Text] [Related]

  • 28. Laser-induced choroidal neovascularization in mice attenuated by deficiency in the apelin-APJ system.
    Hara C, Kasai A, Gomi F, Satooka T, Sakimoto S, Nakai K, Yoshioka Y, Yamamuro A, Maeda S, Nishida K.
    Invest Ophthalmol Vis Sci; 2013 Jun 21; 54(6):4321-9. PubMed ID: 23722395
    [Abstract] [Full Text] [Related]

  • 29. Eicosapentaenoic acid is anti-inflammatory in preventing choroidal neovascularization in mice.
    Koto T, Nagai N, Mochimaru H, Kurihara T, Izumi-Nagai K, Satofuka S, Shinoda H, Noda K, Ozawa Y, Inoue M, Tsubota K, Oike Y, Ishida S.
    Invest Ophthalmol Vis Sci; 2007 Sep 21; 48(9):4328-34. PubMed ID: 17724224
    [Abstract] [Full Text] [Related]

  • 30. Matrix metalloproteinases in human choroidal neovascular membranes excised following verteporfin photodynamic therapy.
    Tatar O, Adam A, Shinoda K, Eckert T, Scharioth GB, Klein M, Yoeruek E, Bartz-Schmidt KU, Grisanti S.
    Br J Ophthalmol; 2007 Sep 21; 91(9):1183-9. PubMed ID: 17475706
    [Abstract] [Full Text] [Related]

  • 31. Changes in aqueous vascular endothelial growth factor and pigment epithelial-derived factor levels following intravitreal bevacizumab injections for choroidal neovascularization secondary to age-related macular degeneration or pathologic myopia.
    Chan WM, Lai TY, Chan KP, Li H, Liu DT, Lam DS, Pang CP.
    Retina; 2008 Oct 21; 28(9):1308-13. PubMed ID: 18728623
    [Abstract] [Full Text] [Related]

  • 32. Intravitreal bevacizumab for previously treated choroidal neovascularization from age-related macular degeneration.
    Goff MJ, Johnson RN, McDonald HR, Ai E, Jumper JM, Fu A.
    Retina; 2007 Oct 21; 27(4):432-8. PubMed ID: 17420694
    [Abstract] [Full Text] [Related]

  • 33. Intravitreal bevacizumab vs sub-tenon triamcinolone acetonide for choroidal neovascularization attributable to pathologic myopia.
    Wakabayashi T, Ikuno Y, Gomi F, Hamasaki T, Tano Y.
    Am J Ophthalmol; 2009 Oct 21; 148(4):591-596.e1. PubMed ID: 19589497
    [Abstract] [Full Text] [Related]

  • 34. Clinical and histological findings after intravitreal injection of bevacizumab (Avastin) in a porcine model of choroidal neovascularization.
    Lassota N, Prause JU, Scherfig E, Kiilgaard JF, la Cour M.
    Acta Ophthalmol; 2010 May 21; 88(3):300-8. PubMed ID: 19416113
    [Abstract] [Full Text] [Related]

  • 35. Intravitreal ranibizumab therapy versus photodynamic therapy for idiopathic choroidal neovascularization: a comparative study on visual acuity, retinal and choroidal thickness.
    Shi X, Wei W, Zhang C.
    Chin Med J (Engl); 2014 May 21; 127(12):2279-85. PubMed ID: 24931242
    [Abstract] [Full Text] [Related]

  • 36. Photodynamic therapy for polypoidal choroidal vasculopathy.
    Nowak-Sliwinska P, van den Bergh H, Sickenberg M, Koh AH.
    Prog Retin Eye Res; 2013 Nov 21; 37():182-99. PubMed ID: 24140257
    [Abstract] [Full Text] [Related]

  • 37. Inhibition of choroidal neovascularization by intravitreal ketorolac.
    Kim SJ, Toma HS.
    Arch Ophthalmol; 2010 May 21; 128(5):596-600. PubMed ID: 20457981
    [Abstract] [Full Text] [Related]

  • 38. Macular pigment lutein is antiinflammatory in preventing choroidal neovascularization.
    Izumi-Nagai K, Nagai N, Ohgami K, Satofuka S, Ozawa Y, Tsubota K, Umezawa K, Ohno S, Oike Y, Ishida S.
    Arterioscler Thromb Vasc Biol; 2007 Dec 21; 27(12):2555-62. PubMed ID: 17932319
    [Abstract] [Full Text] [Related]

  • 39. RETRACTED: Influence of choroidal neovascularization and biodegradable polymeric particle size on transscleral sustained delivery of triamcinolone acetonide.
    Kadam RS, Tyagi P, Edelhauser HF, Kompella UB.
    Int J Pharm; 2012 Sep 15; 434(1-2):140-7. PubMed ID: 22633904
    [Abstract] [Full Text] [Related]

  • 40. Inhibition of choroidal neovascularization with an anti-inflammatory carotenoid astaxanthin.
    Izumi-Nagai K, Nagai N, Ohgami K, Satofuka S, Ozawa Y, Tsubota K, Ohno S, Oike Y, Ishida S.
    Invest Ophthalmol Vis Sci; 2008 Apr 15; 49(4):1679-85. PubMed ID: 18385091
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.